Abbott opens Singapore research lab

SINGAPORE A United States drug and device manufacturer announced Tuesday that it opened a laboratory in Singapore.

Abbott said the pharmaceutical analytical research laboratory opened in the Southeast Asian city-state's Biopolis research park. The Abbott Park, Ill.-based company said the lab was its first in Southeast Asia and would conduct stability studies, including studies on active drug ingredients and novel formulations, to support regulatory requirements around the world. 

"Abbott has continually increased its investment in R&D over the last decade, resulting in a promising pipeline," Abbott SVP for pharmaceuticals research and development John Leonard said in a statement. "To realize the potential from the growth in Abbott?s early-stage pipeline requires the resources of a truly global R&D organization, and the scientific talent available in Singapore made it a logical choice for Abbott?s expansion in the region."

The company said the work done at the lab will allow it to develop investigational medicines and deliver new treatments to patients faster in areas such as neuroscience and cancer.